PROSPECTUS SUPPLEMENT
|
REGISTRATION NO. 333-89355
|
(To Prospectus dated March 15, 2011)
|
Filed Pursuant to Rule 424(b)(3)
|
Name of Company1
|
Ticker
|
Share
Amounts |
Primary U.S.
Trading Market |
|||
Affymetrix, Inc.
|
AFFX
|
4.0000 |
NASDAQ GS
|
|||
Alkermes, Inc.
|
ALKS
|
4.0000 |
NASDAQ GS
|
|||
Amgen Inc.
|
AMGN
|
64.4800 |
NASDAQ GS
|
|||
Biogen Idec Inc.
|
BIIB
|
26.9500 |
NASDAQ GS
|
|||
Enzon Pharmaceuticals, Inc.
|
ENZN
|
3.0000 |
NASDAQ GM
|
|||
Gilead Sciences, Inc.
|
GILD
|
64.0000 |
NASDAQ GS
|
|||
Human Genome Sciences, Inc.
|
HGSI
|
8.0000 |
NASDAQ GM
|
|||
Life Technologies Corporation
|
LIFE
|
8.1774 |
NASDAQ GS
|
|||
QLT Inc.
|
QLTI
|
5.0000 |
NASDAQ GS
|
|||
Shire plc
|
SHPGY
|
6.8271 |
NASDAQ GS
|